People | December 13, 2022
Peter Bains appointed Additional Director of Biocon
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
The company hopes to build on this momentum in the coming quarters and continue to focus on our key brands to drive sustainable profitable growth
Viehbacher brings extensive international experience in large pharmaceutical and entrepreneurial biotech companies
This will not only strengthen the country’s overall position in the global vaccine industry but also reduce its reliance on foreign vaccines
Strides was granted a Competitive Generic Therapy (CGT) designation for its ANDA.
Docosanol Cream, 10% (OTC) has an estimated market size of US$60 million for twelve months ending December 2021 according to IQVIA
Trelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is associated with less inhaler teaching time compared to other commonly used inhalers
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules
Subscribe To Our Newsletter & Stay Updated
